Τόμος 4 (1990) – Τεύχος 2 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 4 (1990) – Issue 2 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Department of Ophthalmology and Ophthalmology Research Center University of Coimbra, Coimbra, Portugal

Accepted for publication: March 25, 1989

pharmakonpress[at]pharmakonpress[.]gr

2.       Kahn, H.A., Hiller, R.: Blindness caused by diabetic retinopathy. Am. J. Ophthalmol. 78: 58 (1974)

3.       Early Treatment Diabetic Retinopathy Study Research: report 1: Photocoagulation for Diabetic Macular Edema. Arch. Ophthalmol. 103: 1796 (1985)

4.       Ashton. N.: Vascular changes in diabetes with particular reference to retinal vessels: Preliminary report. Br. J. Ophthalmol. 33: 404 (1949)

5.       Cogan, D.G., Kuwabara, T.: Capillary shunts in the pathogenesis of diabetic retinopathy. Diabetes 12: 13 (1963)

6.       Cunha-Vaz, J.G., Ashton, N., Shakib, M.: Studies on the permeability of the blood-retinal barrier I, On the existence, development and site of a blood-retinal barrier. Br. J. Ophthalmol. 50: 441 (1966)

7.       Klein, R., Klein, B.E., Neider, M.W., Hubbard, L., Meuer, S., Brothers, R.J.: Diabetic retinopathy as detected using ophthalmoscopy, a nomydriatic camera and a standard fundus camera. Ophthalmology 92 (4): 485 (1984)

8.       Cunha-Vaz, J.G.: Diabetic retinopathy: Human and experimental Studies. Trans. Ophthalmol. Soc. U.K. 92: 111 (1972)

9.       Zeimer, R.C., Cunha-Vaz, J.G., Johnson, M.E.: Studies on the technique of vitreous fluorophotometry. Invest. Ophthalmol. Vis. Sci. 22: 668 (1982)

10.     Cunha-Vaz, J.G., Abreu, J.R., Campos, A.J., Figo, G.: Early breakdown of the blood-retinal barrier in diabetes. Br. J. Ophthalmol. 59: 649 (1975)

11.     Waltman, S.R., Oestrich, C., Krupin, T., Hanish, S., Ratzan, S., Santiago, J., Kilo, C.: Quantitative vitreous fluorophotometry: A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Diabetes 27: 85 (1978)

12.     Cunha-Vaz, J.G., Maurice, D.M.: The active transport of fluorescein by the retinal vessels and the retina. J. Physiol. 191: 467 (1967)

13.     Cunha-Vaz, J.G., Gray, J.R., Zeimer, R.C., Mota, M.C., Ishimoto, B.M., Leite, E.: Characterization of the early stages, of diabetic retinopathy by vitreous fluorophotometry. Diabetes 34: 53 (1985)

14.     Diabetic Retinopathy Study Research Group: report 7. A modification of the Airlie House classification of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 21: 210 (1981)

15.     Cunha-Vaz, J.G. Mota, M.C., Leite, E., Abreu, JR., Ruas, M.A.: Effect of sorbinil on the blood-retinal barrier in early diabetic retinopathy. Diabetes 35: 575 (1986)

16.     Leite, E., Mota, M.C., Faria de Abreu, J.R., Cunha-Vaz, J.G.: Effect of calcium dobesilated on the blood-retinal barrier in early diabetic retinopathy. Int. Ophthalmol. 14: 81 (1990)

17.     Schmidt, M., Michael, M.: Inhibition of sorbitol formation in human erythrocytes by calcium dobesilate. Drug Res. 39: 493 (1989)

18.     Falkay, G., Kovacs, L.: Calcium dobesilate (Doxium) as a prostaglandin synthetase inhibitor in pregnant human myometrium in vitro. Experientia 40: 190 (1984)

19.     Bussolino, F., Biffignandi, P., Arese, P.: Platelet-activating factor. A powerful lipid autocoid. Possibly involved in microangiopathy. Acta Haematologica 75: 3, 129 (1986)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr